These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 14649884)

  • 21. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
    Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2019 Mar; 23(3):333-342. PubMed ID: 30544335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
    Vogelbaum MA; Sampson JH; Kunwar S; Chang SM; Shaffrey M; Asher AL; Lang FF; Croteau D; Parker K; Grahn AY; Sherman JW; Husain SR; Puri RK
    Neurosurgery; 2007 Nov; 61(5):1031-7; discussion 1037-8. PubMed ID: 18091279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.
    Kunwar S; Prados MD; Chang SM; Berger MS; Lang FF; Piepmeier JM; Sampson JH; Ram Z; Gutin PH; Gibbons RD; Aldape KD; Croteau DJ; Sherman JW; Puri RK;
    J Clin Oncol; 2007 Mar; 25(7):837-44. PubMed ID: 17327604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer.
    Kawakami K; Kawakami M; Puri RK
    J Immunol; 2002 Dec; 169(12):7119-26. PubMed ID: 12471149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.
    Rand RW; Kreitman RJ; Patronas N; Varricchio F; Pastan I; Puri RK
    Clin Cancer Res; 2000 Jun; 6(6):2157-65. PubMed ID: 10873064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical studies with IL-13PE38QQR for therapy of malignant glioma.
    Joshi BH; Husain SR; Puri RK
    Drug News Perspect; 2000 Dec; 13(10):599-605. PubMed ID: 12879131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture.
    Liu TF; Cohen KA; Willingham MC; Tatter SB; Puri RK; Frankel AE
    J Neurooncol; 2003 Oct; 65(1):77-85. PubMed ID: 14649887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor regression mechanisms by IL-13 receptor-targeted cancer therapy involve apoptotic pathways.
    Kawakami M; Kawakami K; Puri RK
    Int J Cancer; 2003 Jan; 103(1):45-52. PubMed ID: 12455052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
    Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
    Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice.
    Li C; Hall WA; Jin N; Todhunter DA; Panoskaltsis-Mortari A; Vallera DA
    Protein Eng; 2002 May; 15(5):419-27. PubMed ID: 12034862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
    Kawakami K; Kawakami M; Liu Q; Puri RK
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Puri RK
    Croat Med J; 2003 Aug; 44(4):455-62. PubMed ID: 12950150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
    Kawakami K; Husain SR; Bright RK; Puri RK
    Cancer Gene Ther; 2001 Nov; 8(11):861-8. PubMed ID: 11773976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
    Joshi BH; Kawakami K; Leland P; Puri RK
    Clin Cancer Res; 2002 Jun; 8(6):1948-56. PubMed ID: 12060640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
    Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4.
    Kornmann M; Kleeff J; Debinski W; Korc M
    Anticancer Res; 1999; 19(1A):125-31. PubMed ID: 10226533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.
    Debinski W; Obiri NI; Powers SK; Pastan I; Puri RK
    Clin Cancer Res; 1995 Nov; 1(11):1253-8. PubMed ID: 9815919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain.
    Kawakami K; Joshi BH; Puri RK
    Hum Gene Ther; 2000 Sep; 11(13):1829-35. PubMed ID: 10986556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells.
    Debinski W; Miner R; Leland P; Obiri NI; Puri RK
    J Biol Chem; 1996 Sep; 271(37):22428-33. PubMed ID: 8798406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.